Form 4 for IRON Disc Medicine, Inc.
Accepted 2026-06-30 17:49:29 ET · period of report 2026-06-26 · accession 0001193125-26-290902 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-06-30 17:49 | 2026-06-26+ | IRON | Khara Rahul | CLO | M - OptEx | $14.69 | +2,500 | 53.8K | +5% | +$36.7K |
| DMT | 2026-06-30 17:49 | 2026-06-26+ | IRON | Khara Rahul | CLO | S - Sale+OE | $75.00 | -2,500 | 52.2K | -5% | -$187.5K |
| DMT | 2026-06-30 17:49 | 2026-06-26+ | IRON | Khara Rahul | CLO | M - OptEx | $0.00 | -2,500 | 54.8K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-26 | M | A | 851 | $14.69 | 53,024 | D | — | — | (F1) The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. |
| 2 | Common | Common Stock | 2026-06-26 | S | D | 851 | $75.00 | 52,173 | D | — | — | (F1) The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. |
| 3 | Common | Common Stock | 2026-06-29 | M | A | 1,649 | $14.69 | 53,822 | D | — | — | (F1) The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. |
| 4 | Common | Common Stock | 2026-06-29 | S | D | 1,649 | $75.00 | 52,173 | D | — | — | (F1) The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-06-26 | M | D | 851 | $0.00 | 56,453 | D | $14.69 · — to 2032-02-07 | 851 Common Stock | (F1) The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. (F2) The shares underlying this option are fully vested and exercisable as of the date hereof. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-06-29 | M | D | 1,649 | $0.00 | 54,804 | D | $14.69 · — to 2032-02-07 | 1,649 Common Stock | (F1) The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. (F2) The shares underlying this option are fully vested and exercisable as of the date hereof. |